| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |